Jim Cramer - Mad MoneyElanco Animal HealthELANBUYAug 05, 2026

Is impressed with their turnaround.

Is up 17% in August. It's all about animal health, an enormous industry. They have a fine product pipeline, and all products' revenues have climbed from $350-400 million to $450 million. Cheap at 14x PE and 1x book.

Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.